GPT and metabolic dysfunction-associated steatotic liver disease: The reproducibility of measuring AST levels or platelet counts is questionable, (28) up to 80% of patients with NAFLD have AST and ALT levels within normal ranges, even in clinically significant advanced fibrosis due to NASH (29).